Could zapping cancer spots with radiation save young lives?
NCT ID NCT06796543
First seen Apr 25, 2026 · Last updated Jun 20, 2026 · Updated 9 times
Summary
This study tests whether giving targeted radiation to cancer that has spread (metastases) can help children and young adults with sarcoma live longer. About 70 participants under 39 with newly diagnosed soft tissue or bone sarcoma will receive consolidative radiation therapy. Researchers will track how long patients go without cancer progression or death, compared to past outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHABDOMYOSARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins Hospital
RECRUITINGBaltimore, Maryland, 21287, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sibley Memorial Hospital
RECRUITINGWashington D.C., District of Columbia, 20016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
consolidative radiation therapy
What this could lead to
If successful, this approach could improve survival for young patients with sarcoma that has spread, by using targeted radiation to kill remaining cancer cells.
What could go wrong
This is an early study with no control group, comparing results to historical data. It may not show a survival benefit, and radiation can cause side effects like fatigue or damage to nearby organs.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.